USE OF 5HT4 RECEPTOR ANTAGONIST IN MANUFACTURE OF MEDICAMENT FOR PROPHYLAXIS OR TREATMENT OF ATRIAL FIBRILLATION

USE OF 5HT4 RECEPTOR ANTAGONIST IN MANUFACTURE OF MEDICAMENT FOR PROPHYLAXIS OR TREATMENT OF ATRIAL FIBRILLATION

PROBLEM TO BE SOLVED: To provide a medicament for the prophylaxis or treatment of heart diseases in a mammal. SOLUTION: The invention relates to the pharmaceutical composition for oral administration of a tablet, a troche agent or a lozenges agent or encapsulated in a hard gelatin capsule as powder...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: GOUT BERNARD EMILE JOSEPH, SHEPHERD GILLIAN LOUISE, PATEL BELA RAJIV, BONHOMME MIREILLE MARGUERITE J, AMIN NEETA BALKRISHAN, BRIL ANTOINE M A, ILSON BERNARD ENNO
Format: Patent
Sprache:eng
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:PROBLEM TO BE SOLVED: To provide a medicament for the prophylaxis or treatment of heart diseases in a mammal. SOLUTION: The invention relates to the pharmaceutical composition for oral administration of a tablet, a troche agent or a lozenges agent or encapsulated in a hard gelatin capsule as powder or a pellet form containing 50-120 mg (measured as a free base) of a N-[(1-n-butyl-4-piperidinyl) methyl]-3,4-dihydro-2H-[1, 3]oxazino[3, 2-a]indole-10-carboxamide (SB207266) or a pharmaceutically acceptable salt thereof and pharmaceutically acceptable carriers. COPYRIGHT: (C)2007,JPO&INPIT